TG Therapeutics Inc. Stock
Price
Target price
€26.36
€26.36
-0.940%
-0.25
-0.940%
€48.84
16.01.26 / Tradegate
WKN: A1JXW7 / Symbol: TGTX / Name: TG Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
TG Therapeutics Inc. Stock
TG Therapeutics Inc. shows a slight decrease today, losing -€0.250 (-0.940%) compared to yesterday.
Our community is currently high on TG Therapeutics Inc. with 5 Buy predictions and 1 Sell predictions.
With a target price of 48 € there is a hugely positive potential of 82.13% for TG Therapeutics Inc. compared to the current price of 26.36 €.
So far the community has only identified positive things for TG Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | -0.940% | 7.637% | 0.515% | -6.889% | 1.385% | 112.575% | -35.853% |
| Ardelyx Inc. | -3.030% | -12.646% | 13.772% | 15.995% | 18.404% | 100.586% | 1.785% |
| Evolus Inc | -0.470% | -12.863% | -28.205% | -58.000% | -22.936% | -46.154% | -12.244% |
| Champions Oncology Inc | 2.560% | 7.143% | -4.762% | -31.818% | 3.448% | 53.061% | -34.066% |
Comments
TG Therapeutics (NASDAQ:TGTX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $49.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $60.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat